David Parry

Global Franchise Head P & ma and he (Ddr, Trop2 Adc, Io Bsabs, Solid Tumour Early Assets and Bd) @阿斯利康

Stockport, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Sep 2019 — Present

Global Franchise Head P & ma and he (Ddr, Trop2 Adc, Io Bsabs, Solid Tumour Early Assets and Bd) @阿斯利康

View department →

Heading up Global Pricing and Market Access and Health Economics Teams for DNA Damage Repair, TROP2 ADC, IO BsABs and solid tumour early assets incl cell therapy and radioconjugates / BD We are a team of 12 highly experienced P & MA and HEOR experts based in central Cambridge UK. We work closely with R&D to ensure clinical trial programmes deliver reimbursable medicines and we then collaborate closely with and support AstraZeneca Country Marketing Teams in the reimbursement submissions and price negotiations for our new oncology medicines.

SKILLS

Regulatory AffairsCardiovascular DiseaseClinical DevelopmentPayer EvidenceHtaProduct LaunchHeorPain MedicinesQuality of LifeReal World EvidenceOutcomes ResearchMarket AccessHealth EconomicsEpidemiologyPharmacoeconomicsHealth Technology AssessmentClinical TrialsPayer SubmissionsPatient Reported OutcomesOncologyRegionalPharmaceutical SalesGlobalLate Stage DevelopmentPharmaceutical IndustryEarly Development

ABOUT DAVID PARRY

Franchise Head Oncology Market Access and Pricing DDR, TROP2 ADC, EARLY PRODUCTS & BD at AstraZeneca Global, Cambridge, UK

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

David Parry — Global Franchise Head P & ma and he (Ddr, Trop2 Adc, Io Bsabs, Solid Tumour Early Assets and Bd) at 阿斯利康 in Stockport, GB | Unifers